Literature DB >> 2156603

The relevance of the DNA index and proliferation rate in the grading of benign and malignant soft tissue tumors.

M C Kroese1, D H Rutgers, I S Wils, J A Van Unnik, P J Roholl.   

Abstract

The relevance of the DNA index (DI) to malignancy grading and the relationships between mitotic score, Ki-67 score, and the proportion of cells in the G1-phase (G1PF) of the cell cycle, as proliferative indicators, were investigated in benign (n = 8) and malignant (n = 46) soft tissue sarcomas. Although DI was not found to be related to the histology of the sarcomas, it was associated with malignancy grade, i.e., 14%, 25%, 42%, and 86% of benign, Grade 1, Grade 2, and Grade 3, respectively had a DI greater than 1. The relevance of aneuploidy in benign tumors is discussed and the literature reviewed. A subgroup of the malignant tumors (n = 13) had both a low mitotic score and a low Ki-67 value. However, a distinct correlation between Ki-67 and the mitotic score could not be shown. For malignant tumours G1PF was related to DI, i.e., low G1PF occurred in tumors with diploid DNA content. Low Ki-67 scores were observed in 59% of diploid tumors and in 20% of aneuploid tumors. However, it appeared that G1PF and Ki-67 were not correlated. In conclusion, (1) benign and Grade 1 tumors were predominantly diploid with high G1PF and low Ki-67 values, (2) most of Grade 3 tumors were aneuploid (86%) with low G1PF and high Ki-67 values, and (3) the group of Grade 2 tumors could be divided into two subgroups either with the characteristics displayed by benign and Grade 1 tumors (DI = 1, low Ki-67 scores, and high G1PF) or with the characteristics exhibited by Grade 3 tumors (DI greater than 1, high Ki-67 scores, and low G1PF). Hence, supplementary to the grading of soft tissue tumors, DI, G1PF, and Ki-67 score could be useful as prognostic parameters in soft tissue tumors.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2156603     DOI: 10.1002/1097-0142(19900415)65:8<1782::aid-cncr2820650819>3.0.co;2-i

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  8 in total

1.  Proliferation markers Ki-67 and p105 in soft-tissue lesions. Correlation with DNA flow cytometric characteristics.

Authors:  S A Swanson; J J Brooks
Journal:  Am J Pathol       Date:  1990-12       Impact factor: 4.307

2.  Prognostic relevance of a novel proliferation marker, Ki-S11, for soft-tissue sarcoma. A multivariate study.

Authors:  P Rudolph; U Kellner; A Chassevent; F Collin; F Bonichon; R Parwaresch; J M Coindre
Journal:  Am J Pathol       Date:  1997-06       Impact factor: 4.307

3.  Image analysis derived ploidy and proliferation indices in soft tissue sarcomas: comparison with clinical outcome.

Authors:  B A Michie; C Black; R P Reid; A Barrett; D L Hamblen
Journal:  J Clin Pathol       Date:  1994-05       Impact factor: 3.411

4.  Clinical significance of molecular expression profiles of Hürthle cell tumors of the thyroid gland analyzed via tissue microarrays.

Authors:  Axel Hoos; Alexander Stojadinovic; Bhuvanesh Singh; Maria E Dudas; Denis H Y Leung; Ashok R Shaha; Jatin P Shah; Murray F Brennan; Carlos Cordon-Cardo; Ronald Ghossein
Journal:  Am J Pathol       Date:  2002-01       Impact factor: 4.307

5.  [Histological grading of soft tissue sarcomas: stratification of G2-sarcomas in low- or high-grade malignant tumors].

Authors:  P Meister
Journal:  Pathologe       Date:  2005-03       Impact factor: 1.011

6.  Flow cytometric S-phase fraction in soft-tissue sarcoma: prognostic importance analysed in 160 patients.

Authors:  P Gustafson; M Fernö; M Akerman; B Baldetorp; H Willén; D Killander; A Rydholm
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

7.  The clinical value of flow cytometric DNA content analysis in patients with soft tissue sarcomas.

Authors:  M Samur; A Pamir; H Akbulut; S Erekul; Y Sağlik; Y Yildiz; D Dinçol; F Içli
Journal:  Sarcoma       Date:  1999

8.  Nuclear DNA-Content in Mesenchymal Lesions in Dogs: Its Value as Marker of Malignancy and Extent of Genomic Instability.

Authors:  Kim M Boerkamp; Gerard R Rutteman; Marja J L Kik; Jolle Kirpensteijn; Christoph Schulze; Guy C M Grinwis
Journal:  Cancers (Basel)       Date:  2012-12-03       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.